WVE Paul Bolno sells $2.2M worth of shares
Aug 27, 2025, 4:36 AM
0.00%
What does WVE do
Wave Life Sciences is a clinical-stage biotechnology company focused on RNA medicines, utilizing its PRISM platform to develop treatments for disorders like Duchenne muscular dystrophy and Huntington’s disease. Founded in 2015, it employs 266 people and is advancing RNA-targeting modalities such as editing and interference.
Paul Bolno sold 217,351 shares of WVE on 22 August at $10.10 per share, worth a total of $2.2M. They now own 121,000 WVE shares, or a 64% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.